Real Chemistry Health Care Media Lounge at SXSW 2022

At SXSW 2022, Real Chemistry convened health care’s leading innovators to discuss the issues
driving our industry forward. Hosted in-person in Austin, Texas and also on YouTube Live, the Real Chemistry Health Care Media Lounge drove conversation, connection and community. Speakers included: 

• Cherié Butts, PhD, Medical Director, Therapeutics Development Unit of Biogen

• Sebastian Guth, President of the Americas, Bayer Pharmaceuticals

• Geeta Nayyar, MD, MBA, SVP, Chief Medical Officer, Salesforce

• Charlotte Owens, MD, VP, Head of the Center for Health Equity and Patient Affairs, Takeda

• Sam Stolpe, PharmD, MPH, Senior Director, Healthcare Quality Strategy, Johnson & Johnson

• Shamika Williams, Senior Director, Strategy & Marketing HBCUs, Bristol Myers Squibb

Health innovation was definitely on the rise at SXSW. While there was a lot of buzz about Web3 (crypto, NFTs, blockchain, trusted community, content ownership), health care played a bigger role at the conference than ever before. You won't want to miss key topics from the event, including:

• How health care companies are well-positioned to weather the data privacy storm

• Making health care advertising less interruptive and more worth our time, attention, and action

• Driving outcomes for health equity by moving beyond the moment to a movement

• Exploring the intersection of science and access to equitable health

• How to solve the health care industry’s talent crisis

• The evolving oncology landscape and the impact of RWD and innovation on value & access

If you or your company are interested in learning more about how Real Chemistry is driving global health innovation, please contact us.

Click on the session title to view the video recording.

Taking a Fresh Look at Clinical Trial Recruitment Using Innovative Data, Strategies and Tactics

• Cherié Butts, PhD, Medical Director, Therapeutics Development Unit, Biogen

• Bryan J. Hansen, PhD, Director of Data Science and Digital Health, Janssen Research & Development

• Kelly McKee, Vice President, Patient Cloud, Medidata Solutions

• Deena Shakir, Partner, Lux Capital (moderator)

Is the Cookie Crumbling: A Discussion on How Health Care Companies Are Well Positioned to Withstand the Ongoing Data Privacy Storm

• Angela Radcliffe, Enterprise Digital Innovation Lead, Bristol Myers Squibb

• Felix Zeng, Head of Programmatic and Emerging Revenue, IBM Watson Advertising and Weather

• Chuck Hemann, Practice Leader, Integrated Media, Real Chemistry (moderator)

How Digitally-Enabled Patients are Defining the Future of Health Care

• Shawna Butler, RN, MBA, Nurse Economist & Host, Johnson & Johnson See You Now Podcast

• Geeta Nayyar, MD, MBA, SVP, Chief Medical Officer, Salesforce

• Liane Teplitsky, President, Global Robotics and Technology & Data Solutions, Zimmer Biomet

• Steve Madden, GM, Haymarket Business Media Group, Haymarket Media US (moderator)

Solving Health Care’s Talent Crisis

• Jim Weiss, Chairman and Founder, Real Chemistry

• Shamika Williams, Senior Director, Strategy & Marketing HBCUs, Bristol Myers Squibb

• Heather Landi, Senior Editor, Fierce Healthcare (moderator)

An Inside Look at How One Pharma Company Integrates DE&I Into Each Aspect of the Business

• Sebastian Guth, President of the Americas, Bayer Pharmaceuticals

• Brenda Jimenez, News Anchor, KWEX Univision 41 San Antonio (moderator)

Making Health Care Advertising Less Interruptive and More Worth Our Time, Attention, and Action

• Maureen Alves, EVP, Head of Planning, 21GRAMS

• Laryssa Wozniak, Senior Director, Marketing, Ocugen

• Seth Duncan, Chief Data Officer, Real Chemistry (moderator)

Exploring the Intersection of Science and Access to Equitable Health

• Charlotte Owens, MD, VP, Head of the Center for Health Equity and Patient Affairs, Takeda

• Steve Madden, GM, Haymarket Business Media Group, Haymarket Media US (moderator)

The Evolving Oncology Landscape and the Impact of RWD and Innovation on Value & Access

• Joseph Alvarnas, MD, Vice President of Government Affairs, City of Hope

• Sam Stolpe, PharmD, MPH, Senior Director, Healthcare Quality Strategy, Johnson & Johnson

• Jason Tse, Head of Value & Access, Real Chemistry (moderator)

Sustainability and PPE

• Joe Rosenberg, Founder, Co-CEO, Canopy

• Kim Rosenberg, Founder, Co-CEO, Canopy

Purpose Centricity as a Business Imperative

• Andy Coccari, MBA, Chief Development Officer, March of Dimes

• Ryan Flinn, Head of Communications, Resilience

• Wendy Lund, Chief Communications Officer, Organon

• Jewel Jones, Health Equity & Justice Practice Leader, Real Chemistry (moderator)

How Big Tech is Changing the Face of Health Care

• Hon Pak, MD, Chief Medical Officer, Samsung Electronics America

• Robin Raskin, Founder, The Virtual Events Group

• Jory Des Jardins, Chief Marketing Officer, Countable (moderator)

Health Care Media Lounge Video Recordings

Taking a Fresh Look at Clinical Trial Recruitment Using Innovative Data, Strategies and Tactics

Is the Cookie Crumbling: A Discussion on How Health Care Companies Are Well Positioned to Withstand the Ongoing Data Privacy Storm

How Digitally-Enabled Patients are Defining the Future of Health Care

Solving Health Care’s Talent Crisis

An Inside Look at How One Pharma Company Integrates DE&I Into Each Aspect of the Business

Making Health Care Advertising Less Interruptive and More Worth Our Time, Attention, and Action

Exploring the Intersection of Science and Access to Equitable Health

The Evolving Oncology Landscape and the Impact of RWD and Innovation on Value & Access

Sustainability and PPE

Purpose Centricity as a Business Imperative

How Big Tech is Changing the Face of Health Care